Verpooten G F, Nuyts G D, Hoylaerts M F, Nouwen E J, Vassanyiova Z, Dlhopolcek P, De Broe M E
Department of Nephrology-Hypertension, University of Antwerp, Belgium.
Clin Chem. 1992 May;38(5):642-7.
Urinary intestinal alkaline phosphatase (EC 3.1.3.1; IAP) is a marker of the S3 segment of the human kidney proximal tubule. An accurate enzyme-antigen immunoassay (EAIA) with a high-affinity specific monoclonal antibody (IAP250) developed for this marker has a detection limit below the lowest IAP activity found in urine samples of normal subjects. The intra- and interassay CVs were less than 5%. Mean analytical recovery of pure IAP added to urine was 102% (SD 6%), and the EAIA results correlated well with immunoreactivity (measured by a sandwich ELISA), suggesting that the EAIA detected all of the IAP in urine. In healthy individuals (ages 20-80 years) the IAP concentrations, expressed as urinary creatinine ratios, ranged from 0.1 to 2.0 U/g (5-95 percentiles) without major differences related to sex and age. Workers exposed to mercury, which affects the S3 segment, showed an increased IAP elimination; abusers of analgesics, which affect more distal parts of the nephron, did not. As opposed to currently measured markers, the EAIA offers easy, accurate, and precise measurement of early alterations in the S3 segment.
尿肠碱性磷酸酶(EC 3.1.3.1;IAP)是人类肾近端小管S3段的标志物。针对该标志物开发的一种采用高亲和力特异性单克隆抗体(IAP250)的精确酶抗原免疫测定法(EAIA),其检测限低于正常受试者尿液样本中发现的最低IAP活性。批内和批间变异系数均小于5%。添加到尿液中的纯IAP的平均分析回收率为102%(标准差6%),且EAIA结果与免疫反应性(通过夹心ELISA测量)相关性良好,这表明EAIA检测到了尿液中的所有IAP。在健康个体(20 - 80岁)中,以尿肌酐比值表示的IAP浓度范围为0.1至2.0 U/g(第5至95百分位数),与性别和年龄无重大差异。接触影响S3段的汞的工人,其IAP清除增加;而滥用影响肾单位更远端部分的镇痛药的人则没有这种情况。与目前所测标志物不同,EAIA能够简便、准确且精确地测量S3段的早期改变。